INNOVATE Corp. — Director's Dealing 2024

Oct 30, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: INNOVATE Corp. (VATE)
CIK: 0001006837
Period of Report: 2024-10-29

Reporting Person: Voigt Paul (Interim CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-10-29	Common Stock	A	95322	—	Acquired	306977	Direct
2024-10-29	Common Stock	A	142857	—	Acquired	449834	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-10-29	Stock option (Right To Buy)	$25	A	100000	Acquired	2033-09-15	Common Stock (100000)	Direct
2024-10-29	Stock option (Right To Buy)	$4.22	A	100000	Acquired	2034-09-15	Common Stock (100000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	7537	Indirect

Footnotes

F1: The restricted stock unit award (the "RSU") was granted on October 11, 2023, subject to stockholder approval of an amendment to the Second Amended and Restated 2014 Omnibus Equity Award Plan (the "Second A&R 2014 Plan") to increase the number of shares of Common Stock available thereunder to satisfy the settlement of the grant (the "Share Approval Condition"), which was approved by the stockholders on October 4, 2024 effective as of October 29, 2024.

F2: The RSU was granted on August 19, 2024, subject to the Share Approval Condition, which was approved by the stockholders on October 4, 2024 effective as of October 29, 2024.

F3: Reporting Person is the Manager of Jessie Holdings LLC and has sole voting and investment control.

F4: The option award was granted with an exercise price of $25.00 per share (retroactively adjusted to reflect the 1-for-10 reverse split of the Common Stock effective as of August 8, 2024), which price was greater than the fair market value per share on the date of the grant.

F5: The option award was granted on September 15, 2023, subject to the Share Approval Condition, which was approved by the stockholders on October 4, 2024 effective as of October 29, 2024.

F6: The reported shares have been retroactively adjusted to reflect the 1-for-10 reverse split of the Issuer's Common Stock effective as of August 8, 2024.

F7: The option award was granted on September 15, 2024 with an exercise price to be set at 110% of the 10-day VWAP on the date of the grant.

F8: The option award was granted on September 15, 2024, subject to the Share Approval Condition, which was approved by the stockholders on October 4, 2024 effective as of October 29, 2024.